Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
39.03
-0.74 (-1.86%)
Streaming Delayed Price
Updated: 9:46 AM EDT, Jul 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gsk Plc ADR
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
30
31
Next >
Benzinga Before The Bell: Gun Safety Bill. Bill Gates's North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24
June 24, 2022
Reuters
Via
Benzinga
Sanofi-GSK's Beta-Containing COVID-19 Vaccine Shows Efficacy Against Omicron
June 24, 2022
Via
Benzinga
This Pharmaceutical Company Is Moving Beyond CBD
June 23, 2022
The applications for cannabidiol (CBD) and cannabinoid-based therapeutics are many. Many novel treatments have been, and are continuing to be, discovered using these compounds. The industry is huge...
Via
Benzinga
Best Stocks For 2022 Recession
June 18, 2022
Recession is in the air in 2022, and I have 3 stocks for recession-proofing your portfolio. Let's look at Walmart, Raytheon Tech, and GlaxoSmithKline.
Via
Talk Markets
Antibiotic Makers Adopt Their Own Environmental Safeguard Standards
June 15, 2022
Via
Benzinga
GSK Shows Positive Pivotal Phase III Data For Its RSV Vaccine Candidate
June 10, 2022
Via
Benzinga
FDA Approves GSK's Measles Vaccine
June 06, 2022
Via
Benzinga
Analyzing GSK's Short Interest
June 15, 2022
GSK's (NYSE:GSK) short percent of float has fallen 17.24% since its last report. The company recently reported that it has 6.02 million shares sold short, which is 0.24% of all...
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, June 13
June 13, 2022
CNBC JPMorgan Remains Bullish On Alibaba And Other Chinese Stocks - Here’s Why
Via
Benzinga
Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern
June 13, 2022
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Friday, June 10
June 10, 2022
Reuters Rebranded McDonald’s Restaurants To Reopen In Russia
Via
Benzinga
GlaxoSmithKline: Dividend Insights
May 16, 2022
Wednesday marks the last chance for investors to receive the next dividend payout from GlaxoSmithKline (NYSE:GSK).
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, June 6
June 06, 2022
Reuters
Via
Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
June 05, 2022
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.
Via
Benzinga
Week In Review: Vivo Raises $600 Million In First Tranche Of China PE Fund
June 04, 2022
Vivo Capital held its first closing of a yuan-denominated private equity fund at $600 million, with a target of bringing the fund to $1.5 billion. Meanwhile, ProfoundBio closed a $70 million Series A+...
Via
Talk Markets
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
June 03, 2022
These biotech stocks face some key make-or-break events in June that could have big implication for their futures.
Via
InvestorPlace
3 Undervalued Dividend Growth Stocks
June 01, 2022
Investors who focus on a strategy of dividend growth stocks have performed better than some broader stock market indices.
Via
InvestorPlace
GSK Confirms Consumer Healthcare Unit Spin-off: What Investors Should Know
June 01, 2022
Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE: GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc.
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Wednesday, June 1
June 01, 2022
Reuters Redbird Capital Buys Italian Football Club AC Milan
Via
Benzinga
Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off
June 01, 2022
Via
Benzinga
3 Biotech Stocks to Buy Before They Boom
June 01, 2022
It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations.
Via
InvestorPlace
Unilever Jumps After Nelson Peltz Joins Board
May 31, 2022
Unilever plc (NYSE: UL) shares traded higher by 8% on Tuesday after the company announced activist investor Nelson Peltz is joining the company's board of directors.
Via
Benzinga
GlaxoSmithKline Announces $3.3 Billion Buyout To Square Off With Pfizer, Merck
May 31, 2022
The deal could vastly expand GlaxoSmithKline's vaccine offerings.
Via
Investor's Business Daily
Morning Brief: Top Financial Stories Dominating on Tuesday, May 31
May 31, 2022
CNBC Opportunities In Crypto Crash? Top Crypto Firms Hunt For Takeovers
Via
Benzinga
GSK To Scoop Clinical Stage US Biotech Affinivax For $3.3B To Shore Up Vaccine Business
May 31, 2022
Via
Benzinga
Unilever To Add This Activist Investor To Board - What's The Catch?
May 31, 2022
Via
Benzinga
Dow Up Nearly 300 Points, Eyeing Seventh-Straight Daily Win
May 27, 2022
An upbeat core personal consumption expenditures price index for April is boosting investor sentiment at midday after it showed slowing inflation.
Via
Talk Markets
GSK Turnaround Story
May 18, 2022
GSK is already gearing up for what it hopes will be a bright future. On April 13, GlaxoSmithKline announced a $1.9 billion deal to purchase a U.S. biotech company, Sierra Oncology.
Via
Talk Markets
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield
May 16, 2022
Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing.
Via
Talk Markets
HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty
May 12, 2022
Via
Benzinga
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.